Retatrutide and tirzepatide are both Eli Lilly peptides, both 39 amino acids long, and both built on a GIP receptor agonist backbone. The difference is one receptor: retatrutide also activates the glucagon receptor. This post compares the two compounds on…
Retatrutide has now reported topline results from five Phase 3 trials, and every one met its primary endpoint. Eli Lilly plans to submit the triple GIP, GLP-1 and glucagon receptor agonist for US approval in the first quarter of 2027.…
Why Torsena Currently Accepts SEPA and Cryptocurrency If you’ve reached our checkout, you’ll see two payment options: SEPA bank transfer and cryptocurrency. Card payments are coming soon. Here’s what’s available now and how each option works. SEPA Bank Transfer Direct…
The products on this site are supplied strictly for in-vitro and ex-vivo laboratory research. They are not for human or animal consumption.
